Spots Global Cancer Trial Database for folfox regimen
Every month we try and update this database with for folfox regimen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cadonilimab + FOLFOX Versus FOLFOX in the Neoadjuvant Treatment of pMMR/MSS Locally Advanced Colorectal Cancer | NCT06154538 | Locally Advance... | Cadonilimab FOLFOX regimen | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | NCT00016198 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Cadonilimab + FOLFOX Versus FOLFOX in the Neoadjuvant Treatment of pMMR/MSS Locally Advanced Colorectal Cancer | NCT06154538 | Locally Advance... | Cadonilimab FOLFOX regimen | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | NCT00008060 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | NCT00043004 | Colorectal Canc... Metastatic Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin conventional su... radiofrequency ... | 18 Years - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer | NCT01498289 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | FOLFOX regimen docetaxel fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Immunotherapy for Advanced Liver Cancer | NCT05033522 | Hepatocellular ... | AlloStim® immun... FOLFOX regimen Sorafenib Lenvatinib | 18 Years - 80 Years | Immunovative Therapies, Ltd. | |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | NCT00873275 | Colorectal Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin ursodiol RNA analysis gene expression... polymerase chai... western blottin... immunohistochem... laboratory biom... pharmacological... positron emissi... | 18 Years - | City of Hope Medical Center | |
| Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer | NCT00958737 | Colorectal Canc... | FOLFOX regimen CAPOX | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma | NCT03483038 | Pancreatic Aden... | Liposomal Irino... FOLFOX regimen | 18 Years - 99 Years | University of Florida | |
| Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | NCT01167725 | Colorectal Canc... | bevacizumab cetuximab FOLFIRI regimen FOLFOX regimen capecitabine fluorouracil irinotecan hydr... leucovorin calc... mitomycin C oxaliplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy | NCT05394740 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | Regorafenib Nivolumab CapeOX FOLFOX regimen | 20 Years - | National Cancer Center Hospital East | |
| PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy | NCT00364013 | Metastatic Colo... | Panitumumab FOLFOX regimen | 18 Years - | Amgen | |
| Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer | NCT03377842 | Colorectal Canc... Neoadjuvant The... | FOLFOX regimen apatinib and FO... | 18 Years - | Sichuan Provincial People's Hospital | |
| Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer | NCT03377842 | Colorectal Canc... Neoadjuvant The... | FOLFOX regimen apatinib and FO... | 18 Years - | Sichuan Provincial People's Hospital | |
| Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy | NCT05394740 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | Regorafenib Nivolumab CapeOX FOLFOX regimen | 20 Years - | National Cancer Center Hospital East | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | NCT00006479 | Colorectal Canc... Metastatic Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy | NCT03982121 | Colorectal Canc... | FOLFOX regimen Nivolumab Ipilimumab GLA-SE | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma | NCT03483038 | Pancreatic Aden... | Liposomal Irino... FOLFOX regimen | 18 Years - 99 Years | University of Florida | |
| Lidocaine for Oxaliplatin-induced Neuropathy | NCT03254394 | Neuropathy, Pai... Chemotherapy-in... Colorectal Canc... | Lidocaine Hydro... Placebo FOLFOX regimen | 18 Years - | Washington University School of Medicine | |
| A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer | NCT03597581 | Gastrointestina... Gastrointestina... Colorectal Canc... Colorectal Neop... Colorectal Carc... Gastric Cancer Gastric Neoplas... KRAS Mutation-R... CRC Colorectal Canc... | ompenaclid FOLFIRI Bevacizumab FOLFOX regimen | 18 Years - | Inspirna, Inc. | |
| FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer | NCT01418222 | Colorectal Canc... | 5-FU FOLFOX regimen Placebo bevacizumab [Av... leucovorin onartuzumab [Me... | 18 Years - | Genentech, Inc. | |
| Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer | NCT03186326 | Metastatic Colo... MSI | FOLFOX regimen FOLFIRI Protoco... Avelumab Panitumumab Cetuximab Bevacizumab Aflibercept | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | NCT00016978 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | NCT00006115 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach | NCT00004127 | Esophageal Canc... Gastric Cancer | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | University of Chicago | |
| Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma | NCT05108428 | Rectal Adenocar... | Capecitabine Radiation Thera... FOLFOX regimen | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab | NCT06003998 | Colorectal Canc... Peritoneal Meta... | Irinotecan FOLFOX regimen Bevacizumab | 18 Years - | Catharina Ziekenhuis Eindhoven | |
| Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | NCT00043004 | Colorectal Canc... Metastatic Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin conventional su... radiofrequency ... | 18 Years - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors | NCT05712356 | Cholangiocarcin... Gallbladder Can... Gallbladder Car... Intrahepatic Ch... Extrahepatic Ch... Bile Duct Cance... Gall Bladder Ca... Gall Bladder Ca... | LSTA1 Durvalumab Cisplatin Gemcitabine FOLFOX regimen Placebo | 18 Years - | Lisata Therapeutics, Inc. | |
| Organ Preservation in Early Rectal Cancer Patients | NCT03548961 | Rectal Cancer | FOLFOX regimen | 18 Years - | Fox Chase Cancer Center | |
| A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma | NCT03483038 | Pancreatic Aden... | Liposomal Irino... FOLFOX regimen | 18 Years - 99 Years | University of Florida | |
| FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer | NCT01418222 | Colorectal Canc... | 5-FU FOLFOX regimen Placebo bevacizumab [Av... leucovorin onartuzumab [Me... | 18 Years - | Genentech, Inc. | |
| S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer | NCT01498289 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | FOLFOX regimen docetaxel fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy | NCT02590367 | Peripheral Neur... | FOLFOX regimen HD6610 Granule HD6610 Granule ... | 18 Years - 70 Years | Jiangsu Province Hospital of Traditional Chinese Medicine | |
| Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer | NCT04380337 | Rectal Cancer | FOLFOXIRI FOLFOX regimen XELOX IMRT | 18 Years - | Stanford University | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer | NCT03883802 | Colon Cancer | Foxy-5 FOLFOX regimen Tumour resectio... | 18 Years - | WntResearch AB | |
| Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma | NCT03164382 | Liver Cancer Hepatic Carcino... | FOLFOX regimen Sorafenib 200Mg... | 18 Years - 75 Years | Sun Yat-sen University | |
| Non-Operative Management and Early Response Assessment in Rectal Cancer | NCT03904043 | Adenocarcinoma ... | Radiation thera... FOLFOX regimen Functional Asse... Rectal biopsy s... Blood for ctDNA | 18 Years - | Washington University School of Medicine | |
| Organ Preservation in Early Rectal Cancer Patients | NCT03548961 | Rectal Cancer | FOLFOX regimen | 18 Years - | Fox Chase Cancer Center | |
| Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00006468 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer | NCT06123455 | Gastric Cancer | Taurine Sintilimab XELOX regimen SOX regimen FOLFOX regimen | 18 Years - | Tang-Du Hospital | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease | NCT04595266 | Colorectal Canc... Liver Metastasi... | FOLFOX regimen Anti-EGFR or Be... LIVERPEARLS-Iri... | 18 Years - | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer. | NCT05024097 | Rectal Cancer | Etrumadenant (A... Radiation thera... FOLFOX regimen Zimberelimab (A... | 18 Years - 90 Years | Weill Medical College of Cornell University | |
| Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | NCT00043004 | Colorectal Canc... Metastatic Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin conventional su... radiofrequency ... | 18 Years - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | NCT00884767 | Chemotherapeuti... Colorectal Canc... Neurotoxicity | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin gene expression... protein express... proteomic profi... laboratory biom... pharmacogenomic... | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer | NCT00004206 | Ovarian Cancer | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen | NCT05312398 | Metastatic Colo... | Cetuximab FOLFIRI FOLFOX regimen Irinotecan | 18 Years - | University of Campania "Luigi Vanvitelli" | |
| Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00039611 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 15 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer | NCT00008294 | Colorectal Canc... Metastatic Canc... | FOLFOX regimen dexamethasone floxuridine fluorouracil leucovorin calc... oxaliplatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer | NCT00059930 | Colorectal Canc... Metastatic Canc... | FOLFOX regimen dexamethasone floxuridine fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy | NCT00364013 | Metastatic Colo... | Panitumumab FOLFOX regimen | 18 Years - | Amgen | |
| Cadonilimab + FOLFOX Versus FOLFOX in the Neoadjuvant Treatment of pMMR/MSS Locally Advanced Colorectal Cancer | NCT06154538 | Locally Advance... | Cadonilimab FOLFOX regimen | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Non-Operative Management and Early Response Assessment in Rectal Cancer | NCT03904043 | Adenocarcinoma ... | Radiation thera... FOLFOX regimen Functional Asse... Rectal biopsy s... Blood for ctDNA | 18 Years - | Washington University School of Medicine | |
| Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | NCT00003260 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer | NCT06123455 | Gastric Cancer | Taurine Sintilimab XELOX regimen SOX regimen FOLFOX regimen | 18 Years - | Tang-Du Hospital | |
| Immunotherapy for Advanced Liver Cancer | NCT05033522 | Hepatocellular ... | AlloStim® immun... FOLFOX regimen Sorafenib Lenvatinib | 18 Years - 80 Years | Immunovative Therapies, Ltd. | |
| Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer | NCT00103298 | Colorectal Canc... Metastatic Canc... | FOLFOX regimen fluorouracil isolated perfus... leucovorin calc... melphalan oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | NCT03801876 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Thoracic Esopha... | Carboplatin Esophagectomy Intensity-Modul... Paclitaxel Proton Beam Rad... Quality-of-Life... Questionnaire A... FOLFOX regimen CAPOX regimen Docetaxel 5FU | 18 Years - | NRG Oncology | |
| Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | NCT00884767 | Chemotherapeuti... Colorectal Canc... Neurotoxicity | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin gene expression... protein express... proteomic profi... laboratory biom... pharmacogenomic... | 18 Years - | National Cancer Institute (NCI) | |
| Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | NCT00025142 | Colorectal Canc... | FOLFOX regimen fluorouracil gefitinib leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | NCT01167725 | Colorectal Canc... | bevacizumab cetuximab FOLFIRI regimen FOLFOX regimen capecitabine fluorouracil irinotecan hydr... leucovorin calc... mitomycin C oxaliplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00004102 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | NYU Langone Health | |
| First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer | NCT06253611 | Gastric Cancer | Nivolumab FOLFOX regimen EXL01 | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy | NCT05394740 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | Regorafenib Nivolumab CapeOX FOLFOX regimen | 20 Years - | National Cancer Center Hospital East | |
| Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | NCT00070213 | Colorectal Canc... | FOLFOX regimen capecitabine fluorouracil leucovorin calc... oxaliplatin quality-of-life... | 0 Years - 120 Years | Medical Research Council | |
| Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy | NCT02590367 | Peripheral Neur... | FOLFOX regimen HD6610 Granule HD6610 Granule ... | 18 Years - 70 Years | Jiangsu Province Hospital of Traditional Chinese Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
